These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35950888)

  • 1. The role of ex-situ perfusion for thoracic organs.
    Roesel MJ; Wiegmann B; Ius F; Knosalla C; Iske J
    Curr Opin Organ Transplant; 2022 Oct; 27(5):466-473. PubMed ID: 35950888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplanting Marginal Organs in the Era of Modern Machine Perfusion and Advanced Organ Monitoring.
    Resch T; Cardini B; Oberhuber R; Weissenbacher A; Dumfarth J; Krapf C; Boesmueller C; Oefner D; Grimm M; Schneeberger S
    Front Immunol; 2020; 11():631. PubMed ID: 32477321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of Mesenchymal Stem Cells During Machine Perfusion: An Emerging Novel Strategy for Organ Preservation.
    Li J; Peng Q; Yang R; Li K; Zhu P; Zhu Y; Zhou P; Szabó G; Zheng S
    Front Immunol; 2021; 12():713920. PubMed ID: 35024039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential of ex vivo lung perfusion on improving organ quality and ameliorating ischemia reperfusion injury.
    Iske J; Hinze CA; Salman J; Haverich A; Tullius SG; Ius F
    Am J Transplant; 2021 Dec; 21(12):3831-3839. PubMed ID: 34355495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Machine Perfusion of Extended Criteria Donor Organs: Immunological Aspects.
    Kvietkauskas M; Leber B; Strupas K; Stiegler P; Schemmer P
    Front Immunol; 2020; 11():192. PubMed ID: 32180769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ex Vivo Mesenchymal Stem Cell Therapy to Regenerate Machine Perfused Organs.
    Bogensperger C; Hofmann J; Messner F; Resch T; Meszaros A; Cardini B; Weissenbacher A; Oberhuber R; Troppmair J; Öfner D; Schneeberger S; Hautz T
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34063399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in machine perfusion graft viability assessment in kidney, liver, pancreas, lung, and heart transplant.
    Balfoussia D; Yerrakalva D; Hamaoui K; Papalois V
    Exp Clin Transplant; 2012 Apr; 10(2):87-100. PubMed ID: 22432750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of Current Machine Perfusion Therapeutics for Organ Preservation.
    Xu J; Buchwald JE; Martins PN
    Transplantation; 2020 Sep; 104(9):1792-1803. PubMed ID: 32371846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Machine perfusion: new opportunities in abdominal organ transplantation].
    Wettstein D; Hamar M; Cseprekál O; Tóth SJ; Rózsa B; Remport Á; Máthé Z
    Orv Hetil; 2018 Nov; 159(46):1882-1890. PubMed ID: 30450928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothermic reconditioning in organ transplantation.
    Minor T; Paul A
    Curr Opin Organ Transplant; 2013 Apr; 18(2):161-7. PubMed ID: 23313939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ex Vivo Lung Perfusion: A Review of Research and Clinical Practices.
    Chan PG; Kumar A; Subramaniam K; Sanchez PG
    Semin Cardiothorac Vasc Anesth; 2020 Mar; 24(1):34-44. PubMed ID: 32036756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Machine perfusion in organ transplantation: a tool for ex-vivo graft conditioning with mesenchymal stem cells?
    Van Raemdonck D; Neyrinck A; Rega F; Devos T; Pirenne J
    Curr Opin Organ Transplant; 2013 Feb; 18(1):24-33. PubMed ID: 23254699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preserving and rejuvenating old organs for transplantation: novel treatments including the potential of senolytics.
    Matsunaga T; Roesel MJ; Schroeter A; Xiao Y; Zhou H; Tullius SG
    Curr Opin Organ Transplant; 2022 Oct; 27(5):481-487. PubMed ID: 35950886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dawn of liver perfusion machines.
    Detelich D; Markmann JF
    Curr Opin Organ Transplant; 2018 Apr; 23(2):151-161. PubMed ID: 29324518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The current status of stem cell-based therapies during ex vivo graft perfusion: An integrated review of four organs.
    Luijmes SH; Verstegen MMA; Hoogduijn MJ; Seghers L; Minnee RC; Mahtab EAF; Taverne YJHJ; Reinders MEJ; van der Laan LJW; de Jonge J
    Am J Transplant; 2022 Dec; 22(12):2723-2739. PubMed ID: 35896477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current state of hypothermic machine perfusion preservation of organs: The clinical perspective.
    Taylor MJ; Baicu SC
    Cryobiology; 2010 Jul; 60(3 Suppl):S20-35. PubMed ID: 19857479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex-vivo machine perfusion for kidney preservation.
    Hamar M; Selzner M
    Curr Opin Organ Transplant; 2018 Jun; 23(3):369-374. PubMed ID: 29697462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ischemia-free organ transplantation - a review.
    Guo Z; Luo T; Mo R; Zhao Q; He X
    Curr Opin Organ Transplant; 2022 Aug; 27(4):300-304. PubMed ID: 36354255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Machine perfusion for liver transplantation in the era of marginal organs-New kids on the block.
    Czigany Z; Lurje I; Tolba RH; Neumann UP; Tacke F; Lurje G
    Liver Int; 2019 Feb; 39(2):228-249. PubMed ID: 30129192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of normothermic machine perfusion in liver transplantation.
    Martins PN; Buchwald JE; Mergental H; Vargas L; Quintini C
    Int J Surg; 2020 Oct; 82S():52-60. PubMed ID: 32417462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.